Food and Drug Administration Commissioner Marty Makary signed off on the ouster of top vaccine official Peter Marks shortly after being quietly sworn in as the agency’s new leader late last week, four people familiar with the matter told POLITICO.

Moderna (MRNA) shares dropped nearly 12% following news that FDA official Peter Marks will step down on April 5th, causing uncertainty in the biotech sector, particularly for vaccine makers. Yahoo Finance Senior Reporter Anjalee Khemlani joins Morning Brief to discuss how this leadership change could impact companies like Moderna,

Federal regulators were responsible for recalling pet food contaminated with bird flu, which killed household cats.

A national leader in medicine with impeccable credentials, Dr. Makary is imminently qualified to lead the FDA at this important time in the health of our nation,” the email, obtained by STAT, reads. It’s a shaky start for Makary,

Federal efforts that have successfully driven down rates of youth vaping in recent years may be in peril after dramatic staffing cuts at the U.S. Department of Health and Human Services.

As the FDA wavers from cuts, changes and departures under the second Trump administration, another vital figure of the agency is heading for the exit. | In resigning as director of the FDA’s Center for Biologics Evaluation and Research,

A Department of Health and Human Services official delivered an ultimatum to Dr. Peter Marks: either resign or be fired.